Literature DB >> 18273581

[Microcirculation of intensive care patients. From the physiology to the bedside].

H Knotzer1, W Hasibeder.   

Abstract

The microcirculation is unique in its anatomy and physiology and is a self-contained organ system within the human body. It is the site where gas exchange and nutrient supply takes place, but it is also the site which experiences pathological alterations during various shock states and therefore compromises the oxygen supply to tissues and organs. Systemic inflammation for example leads amongst others to increased heterogeneous blood flow, formation of interstitial edema, altered viscosity, leukocyte activation, disturbances in the coagulation system, and to a breakdown of the endothelial barrier function. These alterations inevitably lead to limitations of the oxygen supply to tissues. Without interruption of these pathomechanisms, the dysfunction of the microcirculation will consequently result in organ dysfunction. In this review article a short description of the microcirculatory physiology, the interaction between the macrocirculation and the microcirculation, as well as microcirculatory alterations generated by a systemic inflammatory response will be given. Finally, various therapy options will be described, which, experimentally, can lead to an improvement in microcirculatory dysfunction.

Entities:  

Mesh:

Year:  2008        PMID: 18273581     DOI: 10.1007/s00101-007-1300-z

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  144 in total

Review 1.  Heparan sulphate.

Authors:  S E Stringer; J T Gallagher
Journal:  Int J Biochem Cell Biol       Date:  1997-05       Impact factor: 5.085

2.  Heterogeneity of gut capillary transit times and impaired gut oxygen extraction in endotoxemic pigs.

Authors:  M F Humer; P T Phang; B P Friesen; M F Allard; C M Goddard; K R Walley
Journal:  J Appl Physiol (1985)       Date:  1996-08

Review 3.  Intestinal blood flow.

Authors:  D N Granger; P D Richardson; P R Kvietys; N A Mortillaro
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

4.  Studies on the interaction of Escherichia coli endotoxin with erythrocyte membranes.

Authors:  D V Godin; J M Tuchek; M E Garnett
Journal:  Can J Physiol Pharmacol       Date:  1982-07       Impact factor: 2.273

5.  Prostacyclin but not phentolamine increases oxygen consumption and skin microvascular blood flow in patients with sepsis and respiratory failure.

Authors:  J F Pittet; J S Lacroix; K Gunning; M C Laverriere; D R Morel; P M Suter
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

6.  Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease.

Authors:  Michael C Ling; Terrence D Ruddy; Robert A deKemp; Heikki Ukkonen; Lloyd Duchesne; Lyall Higginson; Kathryn A P Williams; Ruth McPherson; Rob Beanlands
Journal:  Am Heart J       Date:  2005-06       Impact factor: 4.749

7.  Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis.

Authors:  W S Madorin; C M Martin; W J Sibbald
Journal:  Crit Care Med       Date:  1999-02       Impact factor: 7.598

Review 8.  Opening the microcirculation: can vasodilators be useful in sepsis?

Authors:  Mattijn Buwalda; Can Ince
Journal:  Intensive Care Med       Date:  2002-07-27       Impact factor: 17.440

9.  Statin use and mortality within 180 days after bacteremia: a population-based cohort study.

Authors:  Reimar W Thomsen; Heidi H Hundborg; Søren P Johnsen; Lars Pedersen; Henrik T Sørensen; Henrik C Schønheyder; Hans-Henrik Lervang
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

Review 10.  The microcirculation is the motor of sepsis.

Authors:  Can Ince
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

View more
  1 in total

1.  Cutaneous Microvascular Blood Flow and Reactivity in Hypoxia.

Authors:  Benedikt Treml; Axel Kleinsasser; Karl-Heinz Stadlbauer; Iris Steiner; Werner Pajk; Michael Pilch; Martin Burtscher; Hans Knotzer
Journal:  Front Physiol       Date:  2018-03-06       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.